LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global veterinary vaccines market is expected to reach USD 6,893.72 million by 2021, growing at a CAGR of ...
Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...
LYON, France--(BUSINESS WIRE)--BioNet Europe, the French subsidiary of BioNet, a vaccine manufacturer specializing in the development of genetically engineered vaccines, has announced the submission ...
Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results